Review

You have free access to this content

Thalidomide as a Multi-Template for Development of Biologically Active Compounds

Yuichi Hashimoto

Article first published online: 3 APR 2008

DOI: 10.1002/ardp.200700217

Issue

Archiv der Pharmazie

Special Issue: Medicinal Chemistry in Japan

Volume 341, Issue 9, pages 536–547, September 2008

Additional Information

How to Cite

Hashimoto, Y. (2008), Thalidomide as a Multi-Template for Development of Biologically Active Compounds. Arch. Pharm. Pharm. Med. Chem., 341: 536–547. doi: 10.1002/ardp.200700217

Author Information

Email: Yuichi Hashimoto (hashimot@iam.u-tokyo.ac.jp)

Publication History

Issue published online: 3 SEP 2008
Article first published online: 3 APR 2008
Manuscript Revised: 2 JAN 2008
Manuscript Received: 22 OCT 2007

ARTICLE TOOLS

Abstract
References
Cited By

Get PDF (2490K)

References

1
Y.Hashimoto, Bioorg. Med. Chem. 2002, 10, 461–479.
2
J. B.Bartlett, K.Dredge, A. G.Dalgleish, Nat. Rev. Cancer 2004, 4, 314–322.
3
Y.Hashimoto, Curr. Med. Chem. 1998, 5, 163–178.
4
Y.Hashimoto, Mini–Rev. Med. Chem. 2002, 2, 543–551.
- CrossRef,
- PubMed,
- CAS
5
Y.Hashimoto, A.Tanatani, K.Nagasawa, H.Miyachi, Drugs Future 2004, 29, 383–391.
6
T.Hideshima, D.Chauhan, Y.Shima, N.Raje, et al., Blood 2000, 96, 2943–2950.
7
H.Miyachi, A.Azuma, A.Ogasawara, E.Uchimura, et al., J. Med. Chem. 1997, 40, 2858–2865.
8
H.Miyachi, A.Ogasawara, A.Azuma, Y.Hashimoto, et al., Bioorg. Med. Chem. 1997, 5, 2095–2102.
9
H.Miyachi, A.Azuma, T.Kitamoto, K.Hayashi, et al., Bioorg. Med. Chem. Lett. 1997, 7, 1483–1488.
10
T.Ishioka, A.Kubo, Y.Koiso, K.Nagasawa, et al., Bioorg. Med. Chem. 2002, 10, 1555–1566.
11
T.Ishioka, A.Tanatani, K.Nagasawa, Y.Hashimoto, Bioorg. Med. Chem. Lett. 2003, 13, 2655–2658.
12
M.Komoda, H.Kakuta, H.Takahashi, F.Yasuyuki, et al., Bioorg. Med. Chem. 2001, 9, 121–131.
13
H.Kakuta, H.Takahashi, S.Sou, T.Kita, et al., Recent Res. Develop. Med. Chem. 2001, 1, 189–211.
- CAS
14
R.Shimazawa, H.Takayama, Y.Fujimoto, M.Komoda, et al., J. Enzyme Inhib. 1999, 14, 259–275.
15
R.Shimazawa, H.Takayama, F.Kato, M.Kato, Y.Hashimoto, Bioorg. Med. Chem. Lett. 1999, 9, 559–562.
16
S.Sou, S.Mayumi, H.Takahashim, R.Yamasaki, et al., Bioorg. Med. Chem. Lett. 2000, 10, 1081–1084.
17
S.Sou, H.Takahashi, R.Yamasaki, H.Kagechika, et al., Chem. Pharm. Bull. 2001, 49, 791–793.
18
H.Takahashi, S.Sou, R.Yamasaki, M.Sodeoka, Y.Hashimoto, Chem. Pharm. Bull. 2000, 48, 1494–1499.
19
T.Kita, H.Takahashi, Y.Hashimoto, Biol. Pharm. Bull. 2001, 24, 860–862.
20
T.Noguchi, R.Shimazawa, K.Nagasawa, Y.Hashimoto, Bioorg. Med. Chem. Lett. 2002, 12, 1043–1046.
21
H.Sano, T.Noguchi, A.Tanatani, H.Miyachi, Y.Hashimoto, Chem. Pharm. Bull. 2004, 52, 1021–1022.
22
H.Sano, T.Noguchi, A.Tanatani, Y.Hashimoto, H.Miyachi, Bioorg. Med. Chem. 2005, 13, 3079–3091.
23
R.Shimazawa, H.Sano, A.Tanatani, H.Miyachi, Y.Hashimoto, Chem. Pharm. Bull. 2004, 52, 498–499.
24
T.Noguchi, H.Sano, R.Shimazawa, A.Tanatani, et al., Bioorg. Med. Chem. Lett. 2004, 14, 4141–4145.
25
C.Shinji, T.Nakamura, S.Maeda, M.Yoshida, et al., Bioorg. Med. Chem. Lett. 2005, 15, 4427–4431.
26
C.Shinji, S.Maeda, K.Imai, M.Yoshida, et al., Bioorg. Med. Chem. 2006, 14, 7625–7651.
27
S.Lee, C.Shinji, K.Ogura, M.Shimizu, et al., Bioorg. Med. Chem. Lett. 2007, 17, 4895–4900.
28
H.Sano, T.Noguchi, A.Miyajima, Y.Hashimoto, H.Miyachi, Bioorg. Med. Chem. Lett. 2006, 16, 3068–3072.
29
T.Noguchi, H.Fujimoto, H.Sano, A.Miyajima, et al., Bioorg. Med. Chem. Lett. 2005, 15, 5509–5513.
30
S.Inatsuki, T.Noguchi, H.Miyachi, S.Oda, et al., Bioorg. Med. Chem. Lett. 2005, 15, 321–325.
31
T.Yanagawa, T.Noguchi, H.Miyachi, H.Kobayashi, Y.Hashimoto, Bioorg. Med. Chem. Lett. 2006, 16, 4748–4751.
32
H.Aoyama, T.Noguchi, T.Misawa, T.Nakamura, et al., Chem. Pharm. Bull. 2007, 55, 944–949.
33
T.Noguchi, H.Miyachi, R.Katayama, M.Naito, Y.Hashimoto, Bioorg. Med. Chem. Lett. 2005, 15, 3212–3215.
34
T.Noguchi-Yachide, A.Aoyama, M.Makishima, H.Miyachi, Y.Hashimoto, Bioorg. Med. Chem. Lett. 2007, 17, 3957–3961.
35
T.Noguchi–Yachide, H.Miyachi, A.Aoyama, M.Makishima, et al., Chem. Pharm. Bull. 2007, 55, in press.
36
K.Nishimura, Y.Hashimoto, S.Iwasaki, Biochem. Biophys. Res. Commun. 1994, 199, 455–460.
37
H.Miyachi, A.Azuma, E.Hioki, S.Iwasaki, Y.Hashimoto, Biochem. Biophys. Res. Commun. 1996, 244, 426–430.
- CrossRef,
- Web of Science® Times Cited: 32
38
T.Nakamura, T.Noguchi, H.Kobayashi, H.Miyachi, Y.Hashimoto, Chem. Pharm. Bull. 2006, 54, 1709–1714.
39
T.Nakamura, T.Noguchi, H.Miyachi, Y.Hashimoto, Chem. Pharm. Bull. 2007, 55, 651–654.
40
T.Noguchi, C.Shinji, H.Kobayashi, M.Makishima, H.Miyachi, Y.Hashimoto, Biol. Pharm. Bull. 2005, 28, 563–564.
41
O.Nakajima, Y.Sugishita, Y.Hashimoto, S.Iwasaki, Biol. Pharm. Bull. 1994, 17, 742–744.
42
B. A.Janowski, P. J.Willy, T. R.Devi, J. R.Falck, D.Mangelsdorf, Nature 1996, 383, 728–731.
43
J. M.Lehmann, S. A.Kliewer, L. B.Moore, T. A.Smith–Oliver, et al., J. Biol. Chem. 1997, 272, 3137–3140.
44
J. L.Collins, A. M.Fivush, M. A.Watson, C. M.Galardi, et al., J. Med. Chem. 2002, 45, 1963–1966.
45
J. R.Schults, H.Tu, A.Luk, J. J.Repa, et al., Genes Dev. 2000, 14, 2831–2838.
46
N.Tamehiro, Y.Sato, T.Suzuki, T.Hashimoto, et al., FEBS Lett. 2005, 579, 5299–5304.
47
J. J.Repa, S. D.Turley, J. M. A.Lobaccaro, J.Medina, et al., Science 2000, 289, 1524–1529.
48
D. J.Peet, S. D.Turley, W.Ma, B. A.Janowski, et al., Cell 1998, 93, 693–704.
49
B. A.Laffitte, L. C.Chao, J.Li, R.Walczak, et al., Proc. Natl. Acad. Sci. USA 2003, 100, 5419–5424.
50
G.Cao, Y.Liang, C. L.Broderick, B. A.Oldham, et al., J. Biol. Chem. 2003, 278, 1131–1136.
51
S. S.Choe, A. H.Chi, J.-W.Lee, K. H.Kim, et al., Diabetes 2007, 56, 1534–1543.
52
E. T.Kase, G. H.Thoresen, S.Westerlund, K.Hojulund, et al., Diabetologia 2007, 50, 2171–2180.
53
N.Mitro, P. A.Mak, L.Vatgas, C.Godio, et al., Nature 2007, 445, 219–223.
54
K.Dodo, A.Aoyama, T.Noguchi-Yachide, M.Makishima, et al., submitted.
55
M.Farnegardh, T.Bonn, S.Sun, J.Ljunggren, et al., J. Biol. Chem. 2003, 278, 38821–38828.
56
S.Williams, R. K.Bledsoe, J. L.Collins, S.Boggs, et al., J. Biol. Chem. 2003, 278, 27138–27143.
57
R. T.Nolte, G. B.Wisely, S.Westin, J. E.Cobb, et al., Nature 1998, 395, 137–143.
58
S.Hosoda, A.Tanatani, K.Wakabayasgi, Y.Nakamo, et al., Bioorg. Med. Chem. Lett. 2005, 15, 4327–4331.
59
S.Hosoda, A.Tanatani, K.Wakabayashi, M.Makishima, et al., Bioorg. Med. Chem. 2006, 14, 5489–5502.
60
S.Hosoda, Y.Hashimoto, Pure Appl. Chem. 2007, 79, 615–626.
61
M.Kainuma, J.Kauga, S.Hosoda, K.Wakabayashi, et al., Bioorg. Med. Chem. Lett. 2006, 16, 3213–3218.
62
S.Hosoda, Y.Hashimoto, Bioorg. Med. Chem. Lett. 2007, 17, 5414–5418.

Get PDF (2490K)

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

Thalidomide as a Multi-Template for Development of Biologically Active Compounds

Archiv der Pharmazie

How to Cite

Author Information

Publication History

ARTICLE TOOLS

References

More content like this

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

Thalidomide as a Multi-Template for Development of Biologically Active Compounds

Archiv der Pharmazie

How to Cite

Author Information

Publication History

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

References

More content like this